IP Library › Assignment 064497/0294
Patent Assignment
Reel/Frame 064497/0294

Release of Security Interest

Recorded: 2023-08-04 Pages: 14
Assignor
MIDCAP FINANCIAL TRUST, AS AGENT
Executed: 2023-08-02
Assignee
OCULAR THERAPEUTIX, INC.
24 CROSBY DRIVE, BEDFORD, MASSACHUSETTS, 01730
Covered Properties (65)
Drug Delivery Systems and Applications
Application: 16/203,782 →
Publication: US 2019/0167573
Medical Organogel Processes and Compositions
Application: 14/926,707 →
Publication: US 2016/0045602
Hydrogel Drug Delivery Implants
Application: 14/965,258 →
Publication: US 2016/0166504
Ocular Gels or Hydrogels and Microinjectors
Application: 14/878,243 →
Publication: US 2016/0106587
Drug Delivery from Hydrogels
Application: 15/152,739 →
Publication: US 2016/0331738
Shape Changing Drug Delivery Devices and Methods
Application: 15/360,430 →
Publication: US 2017/0143636
Intracameral Drug Delivery Depots
Application: 15/714,633 →
Publication: US 2018/0085307
Ocular Implant Containing a Tyrosine Kinase Inhibitor
Application: 63/106,276 →
Ocular Implant Containing an Active Agent
Application: 63/106,270 →
Intracanalicular Insert Containing a Glucocorticoid
Application: 63/124,176 →
Sustained Release Biodegradable Intracanalicular Inserts Comprising a Hydrogel and Cyclosporine
Application: 63/124,204 →
Sustained Release Biodegradable Intracanalicular Inserts Comprising a Hydrogel and an Active Agent
Application: 63/124,229 →
Methods of Treating Allergic Conjunctivitis
Application: 63/128,565 →
Method of Treating Ocular Diseases in Human Subjects with Intracameral Implants
Application: 63/136,305 →
Intracanalicular Insert Applicator Device
Application: 63/153,316 →
Method of Treating Ocular Diseases in Human Subjects with Intracameral Implants
Application: 63/139,123 →
Punctal Plug and Bioadhesives
Application: 15/766,647 →
Publication: US 2018/0289543
Compositions and Methods for Treating Ocular Diseases
Application: 17/169,020 →
Publication: US 2021/0251893
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
Application: 62/838,796 →
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
Application: 62/838,998 →
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
Application: 62/994,391 →
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
Application: 16/857,463 →
Publication: US 2020/0337989
Intracanalicular Hydrogel Inserts for the Delivery of Anesthetics
Application: 62/838,789 →
Intracanalicular Hydrogel Inserts for the Delivery of Anesthetics
Application: 16/857,458 →
Publication: US 2020/0337993
Hydrogel Implants for Lowering Intraocular Pressure
Application: 62/838,791 →
Hydrogel Implants for Lowering Intraocular Pressure
Application: 62/840,134 →
Hydrogel Implants for Lowering Intraocular Pressure
Application: 62/970,828 →
Hydrogel Implants for Lowering Intraocular Pressure
Application: 16/857,464 →
Publication: US 2020/0337990
Dexamethasone Ophthalmic Inserts for Use in the Treating Allergic Conjunctivitis and Related Conditions
Application: 63/016,030 →
Dexamethasone Intracanalicular Inserts for the Treatment of Dry Eye
Application: 63/052,646 →
Hydrogel Compositions Comprising Cyclosporine and Uses Thereof
Application: 63/082,505 →
Ocular Implant Containing a Tyrosine Kinase Inhibitor
Application: 63/148,463 →
Ocular Implant Containing a Tyrosine Kinase Inhibitor
Application: 17/210,696 →
Publication: US 2021/0308043
Ocular Implant Containing a Tyrosine Kinase Inhibitor
Application: 17/210,719 →
Publication: US 2022/0079876
Implant Injector Device
Application: 63/165,536 →
Ocular Implant Containing an Active Agent
Application: 63/165,423 →
Composite hydrogel drug delivery systems
Patent: 9,254,267 →
Application: 12/218,152 →
Publication: US 2008/0279944
Biocompatible Crosslinked Polymers
Patent: 6,566,406 →
Application: 09/454,900 →
Biocompatible Hydrogels Made with Small Molecule Precursors
Patent: 8,003,705 →
Application: 12/156,085 →
Publication: US 2008/0260802
Biocompatible Polymers and Hydrogels and Methods of Use
Patent: 8,535,705 →
Application: 11/985,588 →
Publication: US 2008/0095736
Dehydrated Hydrogel Precursor-Based, Tissue Adherent Compositions and Methods of Use
Patent: 6,703,047 →
Application: 09/776,120 →
Publication: US 2002/0106409
Dehydrated Hydrogel Precursor-Based, Tissue Adherent Compositions and Methods of Use
Patent: 8,512,749 →
Application: 10/795,132 →
Publication: US 2004/0191277
Adhesive Hydrogels for Ophthalmic Drug Delivery
Patent: 9,125,807 →
Application: 11/825,848 →
Publication: US 2009/0017097
Hydrogel Polymeric Compositions and Methods
Patent: 9,775,906 →
Application: 12/485,192 →
Publication: US 2009/0252781
Hydrogel Polymeric Compositions and Methods
Patent: 9,370,485 →
Application: 14/470,081 →
Publication: US 2014/0363498
Hydrogel Polymeric Compositions and Methods
Application: 15/186,994 →
Publication: US 2016/0296623
Drug Delivery Through Hydrogel Plugs
Patent: 8,409,606 →
Application: 12/704,692 →
Publication: US 2010/0209478
Drug Delivery Through Hydrogel Plugs
Patent: 8,563,027 →
Application: 13/777,103 →
Publication: US 2013/0172268
Method for Applying Flowable Hydrogels to a Cornea
Patent: 8,961,501 →
Application: 12/884,466 →
Publication: US 2012/0071865
Drug Delivery Systems and Applications
Application: 13/234,428 →
Publication: US 2013/0071462
Medical Organogel Processes and Compositions
Patent: 9,205,150 →
Application: 13/705,808 →
Publication: US 2013/0156752
Coated Implants
Application: 15/217,559 →
Publication: US 2017/0020729
Hydrogel Polymeric Compositions and Methods
Drug Delivery Through Hydrogel Plugs
Medical Organogel Processes and Compositions
Hydrogel Drug Delivery Implants
Drug Delivery from Hydrogels
Coated Implants
Shape Changing Drug Delivery Devices and Methods
Intracameral Drug Delivery Depots
Compositions and Methods for Treating Ocular Diseases
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
Intracanalicular Hydrogel Inserts for the Delivery of Anesthetics
Hydrogel Implants for Lowering Intraocular Pressure
Ocular Implant Containing a Tyrosine Kinase Inhibitor
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2015
From: JARRETT, PETER; MCGRATH, MICHAEL J.; EL-HAYEK, RAMI; SAWHNEY, AMARPREET S.
To: INCEPT, LLC
Reel/Frame 036796/0663 →
Assignment of Assignor's Interest Mar 23, 2016
From: JARRETT, PETER; EL-HAYEK, RAMI; SAWHNEY, AMARPREET S.
To: INCEPT, LLC
Reel/Frame 038077/0797 →
Assignment of Assignor's Interest Jun 8, 2016
From: JARRETT, PETER; BLIZZARD, CHARLES D.; SAWHNEY, AMARPREET S.; EL-HAYEK, RAMI
To: INCEPT, LLC
Reel/Frame 038841/0306 →
Assignment of Assignor's Interest Jan 27, 2017
From: JARRETT, PETER; MCGRATH, MICHAEL J.; JARRETT, TIMOTHY S.; EL-HAYEK, RAMI
To: INCEPT, LLC
Reel/Frame 041113/0169 →
Assignment of Assignor's Interest Apr 19, 2018
From: SAWHNEY, AMARPREET S.; DRISCOLL, ARTHUR; BLIZZARD, CHARLES D.; DESAI, ANKITA D.
To: INCEPT, LLC
Reel/Frame 045588/0383 →
Assignment of Assignor's Interest Aug 9, 2018
From: SILVERBERG, NOAH; SILVERBERG, MARK
To: VOOM LLC
Reel/Frame 046753/0590 →
Security Interest Dec 21, 2018
From: OCULAR THERAPEUTIX, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 047845/0171 →
Assignment of Assignor's Interest Apr 24, 2020
From: JARRETT, PETER; EL-HAYEK, RAMI; JARRETT, TIMOTHY S.; LATTRELL, ZACHARY
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 052488/0513 →
Assignment of Assignor's Interest Apr 24, 2020
From: JARRETT, PETER; EL-HAYEK, RAMI; JARRETT, TIMOTHY S.; LATTRELL, ZACHARY
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 052487/0720 →
Assignment of Assignor's Interest Apr 24, 2020
From: JARRETT, PETER; EL-HAYEK, RAMI; JARRETT, TIMOTHY S.; LATTRELL, ZACHARY
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 052488/0108 →
Assignment of Assignor's Interest Apr 24, 2020
From: GOLDSTEIN, MICHAEL; DRISCOLL, ARTHUR; BLIZZARD, CHARLES D.; DESAI, ANKITA
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 052488/0348 →
Assignment of Assignor's Interest Apr 24, 2020
From: JARRETT, PETER; GOLDSTEIN, MICHAEL; EL-HAYEK, RAMI; JARRETT, TIMOTHY S.
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 052489/0559 →
Assignment of Assignor's Interest Aug 14, 2020
From: EL-HAYEK, RAMI; JARRETT, PETER; SAWHNEY, AMARPREET S.
To: INCEPT, LLC
Reel/Frame 053504/0993 →
Assignment of Assignor's Interest Jan 26, 2021
From: VOOM LLC
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 055029/0669 →
Assignment of Assignor's Interest Mar 5, 2021
From: VOOM LLC
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 055504/0936 →
Assignment of Assignor's Interest Mar 12, 2021
From: BLIZZARD, CHARLES D.; DESAI, ANKITA; DRISCOLL, ARTHUR; GOLDSTEIN, MICHAEL
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 055570/0539 →
Assignment of Assignor's Interest Mar 30, 2021
From: BLIZZARD, CHARLES D.; DRISCOLL, ARTHUR; EL-HAYEK, RAMI; GOLDSTEIN, MICHAEL
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 055767/0280 →
Amended and Restated Security Interest Jun 4, 2021
From: OCULAR THERAPEUTIX, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 057254/0290 →
Assignment of Assignor's Interest Sep 29, 2021
From: WONG, ERIK
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 057644/0879 →
Assignment of Assignor's Interest Oct 13, 2021
From: BLIZZARD, CHARLES D.; EL-HAYEK, RAMI; GOLDSTEIN, MICHAEL; JARRETT, PETER
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 057776/0719 →
Assignment of Assignor's Interest Mar 10, 2022
From: GOLDSTEIN, MICHAEL
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 059226/0806 →
Assignment of Assignor's Interest Mar 22, 2022
From: WONG, ERIK; JARRETT, PETER
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 059330/0862 →
Assignment of Assignor's Interest Sep 21, 2022
From: JARRETT, PETER; GOLDSTEIN, MICHAEL; EL-HAYEK, RAMI; JARRETT, TIMOTHY S.
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 061164/0444 →
Assignment of Assignor's Interest Feb 15, 2023
From: BLIZZARD, CHARLES D.; EL-HAYEK, RAMI; GOLDSTEIN, MICHAEL; JARRETT, PETER
To: OCULAR THERAPEUTIX, INC.
Reel/Frame 062706/0577 →
Security Interest Aug 2, 2023
From: OCULAR THERAPEUTIX, INC.
To: BARINGS FINANCE LLC, AS AGENT
Reel/Frame 064476/0368 →